RRBP1 rewires cisplatin resistance in Oral Squamous Cell Carcinoma by regulating YAP-1
O. Shriwas, R. Arya, S. Mohanty, S. Kumar, R. Rath, S. R. Kaushik, M. C. Thakur, F. Pahwa, S. K. D. Majumdar, D. K. Muduly, R. Nanda, R. Dash
This study identifies RRBP1 as a key regulator of cisplatin resistance in OSCC, showing its role in YAP-1 regulation and demonstrating that Radezolid can restore cisplatin sensitivity.
bioRxiv · Mar 18, 2020Cancer Biology